3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium

J Ethnopharmacol. 2006 Feb 20;103(3):461-7. doi: 10.1016/j.jep.2005.09.014. Epub 2005 Nov 2.

Abstract

A new prenylated salicylic acid derivative, 3-farnesyl-2-hydroxy benzoic acid (1), was isolated from the leaves of Piper multiplinervium C. DC. (Piperaceae). It showed anti-Helicobacter pylori activity (MIC 37.5 microg/ml) and antimicrobial activity at MICs between 2.5 and 5 microg/ml against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Mycobacterium smegmatis, Pseudomonas aeruginosa and Candida albicans. Its structure was elucidated by means of MS, 1H and 13C NMR. The ethnomedical claim of Piper multiplinervium to treat stomach aches by the Kuna Indians of Panama may be justified by anti-Helicobacter pylori activity of its MeOH extract.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / isolation & purification
  • Anti-Infective Agents / pharmacology*
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Farnesol / analogs & derivatives*
  • Farnesol / pharmacology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / growth & development
  • Hydroxybenzoates / pharmacology*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Panama
  • Piper / chemistry*
  • Plant Leaves
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development

Substances

  • 3-farnesyl-2-hydroxybenzoic acid
  • Anti-Infective Agents
  • Hydroxybenzoates
  • Farnesol